PROVIDER PROFILE · NPI 1013987148
Thomas Holt
MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
390
Beneficiaries
—
Total drug cost
$27K
Distinct drugs
8
Brand share
32.3%
Top prescribed drugs
Tamsulosin Hcl131 claims
Oxybutynin Chloride86 claims
Cephalexin61 claims
Finasteride41 claims
Mirabegron23 claims
QUALITY · MIPS · 2024
Final MIPS score
77.8
Quality
64.7
Cost
47.0
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.12%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
No data available for this provider in 2025.
CROSS-REFERENCE